McBath Bill to Lower Prescription Drug Costs for Americans Passes House

Measure will cap the out-of-pocket cost of insulin at $35 per month.

March 31, 2022

Washington, D.C. — Today, the Affordable Insulin Now Act, led by Congresswoman Lucy McBath, Congressman Dan Kildee, and Congresswoman Angie Craig, passed the House of Representatives. The measure passed the House on a bipartisan vote of 232-193. Earlier in the day, McBath was joined by her colleagues Congressman Kildee, Congresswoman Craig, and House Majority Whip Jim Clyburn at a press conference outside of the Capitol to urge Congress to immediately pass their legislation to lower costs for families and seniors with diabetes. The bill will lower drug costs for millions of American families. McBath’s video on the bill is available here and below.

“I am so proud to have worked with my colleagues to bring this bill to a vote and secure its passage in the House,” McBath said. “We must bring a measure of certainty and affordability to every American who needs insulin to continue living a healthy life. This is a bill that will lower costs for almost 40 million Americans, and it will save lives.”    

The Affordable Insulin Now Act caps out-of-pocket costs of insulin products at $35 per month for people with private health plans and Medicare Part D plans, including Medicare Advantage drug plans. For commercial plans, $35 dollars will cover the cost of a monthly supply of insulin. For Medicare plans, the bill will cap the cost of all insulin products currently covered by Medicare at $35 a month in out-of-pocket costs. The Affordable Insulin Now Act is a companion measure to legislation introduced by Senator Reverend Raphael Warnock in the Senate, which has also been cosponsored by Senate Majority Leader Chuck Schumer. During President Biden’s first State of the Union address, he endorsed legislation capping the cost of insulin at $35 per month.